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Identification of a new member of the tumor necrosis factor
family and its receptor, a human ortholog of mouse GITR
A.L. Gurney*†, S.A. Marsters†‡, A. Huang*, R.M. Pitti†, M. Mark*, D.T. Baldwin*,
A.M. Gray*, P. Dowd*, J. Brush*, S. Heldens*, P. Schow‡, A.D. Goddard*, 
W.I. Wood*, K.P. Baker*, P.J. Godowski* and A. Ashkenazi‡
The tumor necrosis factor (TNF) and TNF receptor (TNFR)
gene superfamilies regulate diverse biological functions,
including cell proliferation, differentiation, and survival
[1–3]. We have identified a new TNF-related ligand,
designated human GITR ligand (hGITRL), and its human
receptor (hGITR), an ortholog of the recently discovered
murine glucocorticoid-induced TNFR-related (mGITR)
protein [4]. The hGITRL gene mapped to chromosome
1q23, near the gene for the TNF homolog Fas/CD95
ligand [5]. The hGITR gene mapped to chromosome 1p36,
near a cluster of five genes encoding TNFR homologs
[1,6]. We found hGITRL mRNA in several peripheral
tissues, and detected hGITRL protein on cultured
vascular endothelial cells. The levels of hGITR mRNA in
tissues were generally low; in peripheral blood T cells,
however, antigen-receptor stimulation led to a
substantial induction of hGITR transcripts. Cotransfection
of hGITRL and hGITR in embryonic kidney 293 cells
activated the anti-apoptotic transcription factor NF-κB,
via a pathway that appeared to involve TNFR-associated
factor 2 (TRAF2) [7] and NF-κB-inducing kinase (NIK) [8].
Cotransfection of hGITRL and hGITR in Jurkat T leukemia
cells inhibited antigen-receptor-induced cell death. Thus,
hGITRL and hGITR may modulate T lymphocyte survival
in peripheral tissues. 
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Results and discussion
Using a yeast-based signal sequence trap [9], we identi-
fied a human umbilical vein endothelial cell cDNA 
that encodes a new TNF-related ligand, which we
termed hGITRL. The cDNA encodes a 177 amino-acid
polypeptide (Figure 1a), with a calculated mass of 20 kDa,
and with a type 2 transmembrane topology that is charac-
teristic of the TNF family [1]. The hGITRL extracellular
domain (ECD) shows sequence identity particularly to
TNF (21%), Fas ligand (FasL; 21%), Apo2 ligand (Apo2L;
18%), and lymphotoxin α (LTα; 18%) (Figure 1b). We
analyzed the expression of hGITRL mRNA in human
tissues using reverse transcriptase PCR (RT–PCR). We
detected the highest level of hGITRL mRNA expression
in small intestine, ovary, testis and kidney, and lower
levels or no expression in other tissues (Figure 1c). 
To identify a receptor that might recognize hGITRL, we
searched human expressed sequence tag (EST) DNA data-
bases for sequences with homology to the ECDs of TNFR
family members. One such EST enabled us to isolate from
human bone marrow a cDNA that encodes a 241 amino-acid
TNFR homolog with a type 1 transmembrane protein topol-
ogy and a calculated mass of 26 kDa; we termed this recep-
tor hGITR (Figure 2a). It shows the highest sequence
identity (59% overall; 57% extracellular,  64% intracellular)
to a recently discovered murine TNFR homolog, mGITR
[4]. Like mGITR, hGITR contains three cysteine-rich
domains (CRDs); CRD3 has three cysteines, rather than the
more typical four or six cysteines of the TNFR family. In
addition, several stretches of sequence in the intracellular
domain (ICD) are conserved between hGITR and mGITR,
but not in their next-closest relatives, CD27 and 4-1BB
(CDw137). The degree of identity between hGITR and
mGITR (~60%) is similar to that which exists in general
between human and mouse orthologs of other TNFR family
members [1,2]. Further, hGITR displays only 14–28%
sequence identity to other known members of the human
TNFR family. We surmise that the newly identified cDNA
encodes a human ortholog of mGITR. Notable differences
between hGITR and mGITR are the presence of eight
compared with five cysteines in CRD1, and of one com-
pared with four N-linked glycosylation sites in the ECD
(Figure 2a). Northern blot hybridization analyses of several
tissues did not reveal hGITR mRNA (data not shown), but
quantitative RT–PCR indicated hGITR mRNA expression
in peripheral blood leukocytes (PBLs), bone marrow,
spleen, thymus, lung and brain, and relatively lower levels in
other tissues (Figure 2b). Peripheral blood T cells
expressed low levels of hGITR transcript, but responded to
phytohemagglutinin or anti-CD3 antibody treatment by
substantial induction of hGITR mRNA (Figure 2c).
Radiation-hybrid analysis indicated close chromosomal
linkage of the hGITRL gene to the sequence-tagged site
marker D1S2790 and to Genethon marker AFMb352xe9,
which located hGITRL to chromosome 1q23. FasL also
maps to 1q23 [5], and another TNF homolog, OX40 ligand,
maps to 1q25 [10]. The hGITR gene showed linkage to
Stanford marker SHGC-4723, which located hGITR to
1p36.3, a region that also encodes the TNFR homologs
Apo3/DR3 [6], TNFR2, CD30, OX40 and 4-1BB [1].
To test whether hGITR and hGITRL interact, we generated
a soluble histidine-tagged protein consisting of the hGITRL
ECD [11] and created soluble immunoglobulin fusion pro-
teins (immunoadhesins) [12] containing the ECD of hGITR,
mGITR or of other TNFR homologs. In a microtiter plate
assay, hGITRL bound to hGITR-immunoadhesin, but not to
mGITR, TNFR1, TNFR2, DR5 or Fas immunoadhesins
(Figure 3a). In a coprecipitation assay, radiolabeled hGITRL
bound to hGITR-immunoadhesin, but not to DR3, DR4,
DR5, TNFR1, TNFR2, or Fas immunoadhesins (Figure 3b).
Full-length hGITRL, displayed on the surface of transfected
293 cells, bound to hGITR-immunoadhesin, but not to
TNFR1, HVEM or DcR1 immunoadhesins (Figure 3c).
Given that hGITRL transcripts were readily detectable in
human umbilical vein endothelial cells by RT–PCR (data not
shown), we postulated that endothelial cells might express
hGITRL on their surface. Consistent with this notion,
hGITR-immunoadhesin showed specific, though limited,
binding to cultured human umbilical vein endothelial cells
(Figure 3d).
To explore the signaling functions of hGITRL, we tested
its ability to regulate the transcription factor NF-κB, which
is stimulated by TNF [13]. Transfection of hGITR into
293 cells resulted in significant NF-κB activation, as mea-
sured by reporter-gene induction (Figure 4a); coexpression
of hGITRL greatly enhanced this response. Dominant-
negative mutant forms of TRAF2 [7,14] or of NIK [8] sub-
stantially inhibited NF-κB activation by hGITRL–hGITR
(Figure 4b). By contrast, dominant-negative mutants of
the TNFR1-interacting protein RIP [15,16] or of the inter-
leukin-1 and Toll receptor adaptors TRAF6 [17] and
MyD88 [18,19] did not block NF-κB activation by
hGITRL–hGITR. Thus, hGITRL activates NF-κB
through hGITR by engaging a pathway that appears to
involve TRAF2 and NIK, similar to the pathway that
TNF engages through TNFR2. Given that NF-κB activa-
tion has anti-apoptotic effects in many cell types [19], and
that T-cell activation induces hGITR expression, we
tested the effect of hGITRL and hGITR on activation-
induced cell death (AICD) [4]. Anti-CD3 antibody trig-
gered AICD in human Jurkat T leukemia cells (Figure 4c);
transfection of the cells with hGITRL or hGITR inhibited
the response, and coexpression of ligand and receptor pro-
vided nearly complete protection against AICD.
We have identified a ligand–receptor pair that belongs to
the human TNF and TNFR superfamilies. Several obser-
vations indicate that the new human receptor, hGITR, is an
ortholog of mGITR [4]. First, there is substantial sequence
conservation between the two proteins, particularly in the
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Figure 1
Primary structure and mRNA expression of
hGITRL (TNFSF18, Genbank accession
number AF125303). (a) Amino acid sequence:
the predicted transmembrane domain is
underlined, and potential N-linked glycosylation
sites are marked with bullets. (b) Alignment of
the hGITRL extracellular domain with those of
its closest human relatives. Regions that form
β-strands in the crystal structures of TNF and
LTα [1] are marked above with letters.
(c) RT–PCR analysis of hGITRL mRNA
expression in human tissues. PBL, peripheral
blood leukocytes.
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59 STLK-PAAHLIG----------DPSKQN-SLL-----WRANT-DRAFLQDGFSLSNNS
86 LEILQNGLYLIYGQVAPNAN-Y------NDVAP-FEVRLYKNKDMIQTLTNK-SKIQN
124 LVVPSEGLYLIYSQVLFKGQGCP----STHVLLTHTISRIAVS--YQTKVNLLSAIKS
182 LVINETGLYFVYSKVYFRGQSC------NNLPLSHKVYMRNSKY-PQDLVMMEGKMMS
175 LVIHEKGFYYIYSQTYFRFQEEIKENTKNDKQMVQYIYKYT----SYPDPILLMKSAR
99 LLVPTSGIYFVYSQVVFSGKAYSPKATSSPLYLAHEVQLFSSQ--YPFHVPLLSSQKM
136 ------------VGGTYELHVGDTIDLIFNSEHQVLKNNT-YWGIILLANPQF-IS
176 PCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL
231 -----SCYCTTGQMWARSSYLGAVFNLTSADHLYVNVSELSLVNF-EESQTFFGLYKL
231 ------NWSKDAEYGLYSIYQCGIFELKENDRIFVSVTNEHLIDMDHEA-SFFGAFLVG
155 ------VYPGLQEPWLHSMYHGAAFQLTQGDQLSTHTDGIPHLVL-SPSTVFFGAFAL
ICD, which mediates signaling. Second, neither receptor
mRNA is detectable in tissues by northern hybridization,
but low mRNA levels of each are detectable in lymphoid
tissues by RT–PCR. Third, T-cell receptor stimulation
induces a marked increase in mRNA expression of each
gene. Fourth, both receptors confer protection against
AICD in T-cell lines. The fact that hGITRL did not
bind to mGITR is not inconsistent with the suggestion
that hGITR and mGITR are orthologs, because several
TNF family members exhibit species-specific binding to
their receptors [1].
We detected the hGITRL mRNA mainly in peripheral
tissues; stimulation of peripheral blood T cells did not
induce hGITRL mRNA expression (data not shown). In
addition, soluble hGITR bound to vascular endothelial cells,
which suggests that these cells express hGITRL on their
surface. We observed low levels of hGITR mRNA expres-
sion, mainly in lymphoid tissues; however, peripheral blood
T cells expressed abundant hGITR upon stimulation, which
implicates hGITR in T-cell function. In contrast to the
induction of mGITR by dexamethasone in a mouse T-cell
hybridoma [4], we did not find induction of hGITR by dex-
amethasone in peripheral blood T cells (data not shown).
Further studies will be needed to investigate whether
hGITR is regulated by glucocorticoids in thymic T cells.
Consistent with the ability of hGITRL to activate NF-κB,
cotransfection of the ligand and receptor protected human
Jurkat T cells against AICD. These results, together with
the expression data, suggest that hGITRL and hGITR may
modulate T-lymphocyte survival in peripheral tissues and
perhaps during interaction with the vascular endothelium. 
Materials and methods
Isolation and expression of hGITRL and hGITR cDNA
The hGITRL cDNA was isolated from a human umbilical vein endothelial
cell library probed with the 32P-labeled oligonucleotide 5′-AATGGCT-
TATATTTAATTTATGGCCAAGTGGCTCCCAATGCAAACTACAA. The
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Figure 2
Primary structure and mRNA expression of hGITR (TNFRSF18,
Genbank accession number AF1253040). (a) Alignment of the
extracellular domain and transmembrane (TM) sequence of hGITR and
mGITR and the intracellular domain (ICD) sequence of both with that
of human 4-1BB and CD27. Potential N-linked glycosylation sites are
marked with bullets. (b) Quantitative RT–PCR analysis of hGITR
mRNA expression. Results are expressed in relation to the expression
levels in small intestine. (c) T cells were isolated from peripheral blood
of four donors, treated for 24 h with phytohemagglutinin (PHA)
(1 µg/ml) or anti-CD3 antibody (1 µg/ml), and hGITR mRNA was
measured as in (b). The results, shown in relation to buffer-treated T
cells, represent three independent experiments.
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Figure 3
Interaction of hGITR and hGITRL. (a) Each indicated receptor
immunoadhesin was bound to microtiter wells coated with goat anti-
human Fc antibody and incubated with histidine-tagged soluble
hGITRL. Bound ligand was detected with nickel-conjugated horseradish
peroxidase and O-phenylenediamine (Qiagen). (b) 125I-labeled hGITRL
was incubated with each indicated receptor immunoadhesin; receptor-
bound ligand was precipitated with protein A beads, resolved by
electrophoresis and revealed by autoradiography. (c) Human 293 cells
were transiently transfected with a plasmid encoding full-length hGITRL
and the binding of receptor immunoadhesins to the transfected cells
was measured by fluorescence-activated cell sorting (FACS) with
fluorescein-conjugated anti-human Fc antibody. (d) Human umbilical
cord endothelial cells were incubated with hGITR, TNFR1, or Fas
immunoadhesin and binding was analyzed as in (c).
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hGITR cDNA was isolated from a human bone marrow library probed
with the oligonucleotide 5′-GAGGAGTGCTGTTCCGAGTGGGACTG-
CATGTGTGTCCAGC. Soluble hGITRL ECD (amino acids 52–177)
was expressed in Escherichia coli as an amino-terminally His10-tagged
molecule [11]. The hGITR or mGITR ECD (amino acids 1–161 or
1–149) immunoadhesins [12] were expressed in insect cells.
Analysis of mRNA expression
Expression of hGITRL mRNA was analyzed by RT–PCR using first-
strand cDNA from tissues and primers that amplify a 450 bp product
from the coding region of hGITRL. Expression of hGITR mRNA was
assayed by quantitative RT–PCR on a Taqman instrument (ABI) as
described [20], using PCR primers that amplify a 90 bp product from
the coding sequence of hGITR. The authenticity of the PCR products
was confirmed by Southern blot hybridization to the corresponding
cDNA (data not shown). 
NF-κB assay 
Human 293 cells (2 × 105) were transfected by calcium phosphate
precipitation with 0.5 µg of plasmid pGL3-ELAM.tk, which carries a
firefly luciferase gene driven by an NF-κB-responsive element from the
E-selectin gene. In addition, 0.05 µg of a Renilla luciferase reporter
plasmid was transfected for monitoring transfection efficiency (Pharma-
cia), together with the indicated expression plasmids (0.1 µg hGITR;
0.5 µg other expression vectors), and carrier plasmid pRK5D to main-
tain constant DNA amounts. After 24 h, cells were harvested and
luciferase activity was assayed as recommended (Pharmacia). Expres-
sion vectors encoding dominant-negative mutants are described else-
where for TRAF2 (87–501) [14], NIK (K429A, K430A) [8], RIP
(559–671) [16], TRAF6 (289–522) [17] and MyD88 [18].
Analysis of AICD
Human Jurkat T cells (2 × 106) were transfected by Superfect (Qiagen)
with a total of 5 µg plasmid DNA. After 18 h, the cells were washed,
divided in half, and plated in wells coated with either control or anti-CD3
antibody (40 µg/ml) (Pharmingen). Apoptosis was assayed 24 h later by
FACS analysis of annexin V binding (Pharmingen) as described [11].
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Figure 4
Regulation of NF-κB and T cell apoptosis by
hGITRL and hGITR. (a) 293 cells were
transfected with expression plasmids for
hGITRL and hGITR as indicated, and NF-κB
activity (mean ± standard error (SE) of
triplicates) was measured by luciferase
reporter-gene assay 24 h later. (b) 293 cells
were transfected with expression vectors for
hGITRL, hGITR and the indicated dominant-
negative mutants of NF-κB signaling
molecules. (c) Jurkat T cells were transfected
with expression plasmids for hGITRL and
hGITR as indicated, stimulated with control or
anti-CD3 antibody, and analyzed for
apoptosis. The data (mean ± SE of triplicates)
represent three independent experiments. 
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